| Literature DB >> 26159706 |
Pankaj Kumar1, Jan van den Hurk2, Lisanework E Ayalew3, Amit Gaba4, Suresh K Tikoo5,6.
Abstract
Turkey adenovirus 3 (TAdV-3) causes high mortality and significant economic losses to the turkey industry. However, little is known about the molecular determinants required for viral replication and pathogenesis. Moreover, TAdV-3 does not grow well in cell culture, thus detailed structural studies of the infectious particle is particularly challenging. To develop a better understanding of virus-host interactions, we performed a comprehensive proteomic analysis of proteinase K treated purified TAdV-3 virions isolated from spleens of infected turkeys, by utilizing one-dimensional liquid chromatography mass spectrometry. Our analysis resulted in the identification of 13 viral proteins associated with TAdV-3 virions including a novel uncharacterized TaV3gp04 protein. Further, we detected 18 host proteins in purified virions, many of which are involved in cell-to cell spread, cytoskeleton dynamics and virus replication. Notably, seven of these host proteins have not yet been reported to be present in any other purified virus. In addition, five of these proteins are known antiviral host restriction factors. The availability of reagents allowed us to identify two cellular proteins (collagen alpha-1 (VI) chain and haemoglobin) in the purified TAdV-3 preparations. These results represent the first comprehensive proteomic profile of TAdV-3 and may provide information for illustrating TAdV-3 replication and pathogenesis.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26159706 PMCID: PMC4497381 DOI: 10.1186/s13567-015-0214-z
Source DB: PubMed Journal: Vet Res ISSN: 0928-4249 Impact factor: 3.683
Figure 1Purification of TAdV-3 virions. A Strategy for enrichment and purification of TAdV-3 virions. Flow diagram depicts the strategy. B CsCl2 purification of TAdV-3. The lower band containing mature viruses (left panel) subjected to second round of CsCl (right panel). C–E Analysis of TAdV-3 virions purity. Electron micrograph of CsCl purified TAdV-3 negatively stained with 2% aqueous phosphotungstic acid (Direct magnification 100000X) (C) and (direct magnification 150000X) (D). E Analysis of TAdV-3 polypeptides. Purified TAdV-3 proteins were separated by 10–15% SDS-PAGE and analyzed by Western blot using turkey anti-TAdV-3 serum [4,9] and peroxidase-linked goat anti-turkey IgG antibodies (right panel). The identified polypeptides (lane 1) are depicted. Molecular weight markers (MW) in kDa are shown on the left of the panel.
TAdV-3 proteins identified by LC-MS/MS
|
| ||||
|---|---|---|---|---|
|
|
|
|
|
|
| pVI | 24.98 | 146 | 4378 | 69 |
| pIIIA | 57.52 | 59 | 2377 | 96 |
| pVII | 13.20 | 163 | 1984 | 91 |
| IVa2 | 42.36 | 39 | 1046 | 48 |
| Penton Base | 34.17 | 46 | 857 | 54 |
| Hexon | 101.65 | 42 | 659 | 23 |
| pVIII | 21.75 | 35 | 655 | 81 |
| Fiber | 29.13 | 18 | 620 | 29 |
|
|
|
|
|
|
| DBP | 44.21 | 13 | 389 | 12 |
| Sialidase | 64.9 | 9 | 162 | 6 |
| pX | 6.15 | 9 | 137 | 29 |
| Adenain | 25.33 | 9 | 113 | 18 |
| pTP | 70.72 | 7 | 102 | 9 |
| 22 K | 10.51 | 5 | 42 | 29 |
A novel virion-associated viral protein is shown in bold black.
aTheoritical molecular mass.
bA Mascot score ≥35 is significant (p < 0.05).
cSequence coverage is based on peptides with an unique sequence.
Cellular proteins associated with purified TAdV-3 virions identified by LC-MS/MS
|
| ||||
|---|---|---|---|---|
|
|
|
|
|
|
| Actin | 42.36 | 56 | 607 | 38 |
| TAR DNA binding protein 43 | 44.90 | 22 | 656 | 24 |
| Tublin beta5 | 50.28 | 25 | 535 | 21 |
| Tubulin alpha-1A | 50.78 | 19 | 444 | 26 |
| LUC7 like1 | 47.60 | 28 | 482 | 28 |
| Tublin beta3 | 50.09 | 25 | 338 | 20 |
| High mobility group protein B1 | 23.08 | 13 | 349 | 34 |
| High mobility group protein B2 | 23.98 | 24 | 227 | 24 |
| 78 kDa glucose-regulated protein | 72.08 | 21 | 135 | 5 |
| Myeloid protein 1 | 36.41 | 14 | 240 | 23 |
| Desmin | 53.30 | 16 | 212 | 11 |
| Cathelicidin-3 | 16.61 | 5 | 146 | 32 |
| Protein PML | 35.99 | 13 | 158 | 18 |
| Vimentin | 53.16 | 16 | 157 | 17 |
| Splicing factor U2AF | 28.19 | 7 | 154 | 20 |
| Collagen alpha-1 (VI) chain | 110.0 | 5 | 146 | 32 |
| Elongation factor 1-alpha | 49.48 | 6 | 143 | 15 |
| Protein syndesmos | 33.44 | 4 | 140 | 3 |
| Ferritin | 17.13 | 8 | 129 | 22 |
| Serine/arginine-rich splicing factor 5a | 27.15 | 2 | 76 | 7 |
| Fibronectin | 276.017 | 3 | 76 | 2 |
| Gallinacin-2 | 7.49 | 2 | 75 | 12 |
| Cathespsin B | 38.47 | 3 | 70 | 9 |
| Hemoglobinsubunit beta | 16.62 | 6 | 64 | 19 |
| L-amino acid oxidase | 59.08 | 3 | 56 | 3 |
| Hemoglobin subunit alpha-A | 15.10 | 3 | 42 | 17 |
aTheoritical molecular mass.
bA Mascot score ≥35 is significant (p < 0.05).
cSequence coverage is based on peptides with an unique sequence.
Figure 2Proteinase K digestion of purified TAdV-3 virions. A Proteins from purified TAdV-3 untreated (lane 1) or treated (lanes 2–5) with indicated amounts of proteinase K were separated by 10–15% SDS-PAGE, transferred to nitrocellulose and probed by Western blot using anti-TAdV-3 serum. The hexon protein and the fiber protein are depicted by an arrow. Concentration of proteinase K in μg is indicated on top of the panels. B Purified TAdV-3 treated with 20 μg of proteinase K were negatively stained with 2% aqueous phosphotungstic acid and analyzed by transmission electron microscopy. (Direct magnification 50000×, left panel) and (direct magnification 150000×, right panel).
TAdV-3 proteins identified by LC-MS/MS after proteinase K treatment
|
| |||||
|---|---|---|---|---|---|
|
|
|
|
|
|
|
| Hexon | 101.653 | + | 71 | 1327 | 37 |
| PVI | 24.989 | + | 15 | 560 | 32 |
| PVII | 13.201 | + | 24 | 467 | 70 |
|
|
|
|
|
|
|
| Fiber | - | - | - | - | - |
| Penton Base | 34.179 | + | 13 | 153 | 19 |
| PVIII | 21.75 | + | 8 | 135 | 12 |
| Sialidase | 64.9 | + | 2 | 84 | 10 |
| IIIA | 57.52 | + | 10 | 83 | 10 |
| Adenain | 25.33 | + | 2 | 55 | 6 |
| PX | 6.15 | + | 1 | 39 | 13 |
| IVa2 | 42.36 | + | 2 | 35 | 2 |
| DBP | 44.21 | + | 1 | 24 | 2 |
| pTP | - | - | - | - | - |
| 22 K | - | - | - | - | - |
A novel virion-associated viral protein is shown in bold black.
aTheoritical molecular mass.
bpK, proteinase K treatment +.
cA Mascot score ≥35 is significant (p < 0.05).
dSequence coverage is based on peptides with an unique sequence.
Figure 3Identification of viral and host virion proteins. Venn diagrams of viral (A) and host proteins (B) detected in TAdV-3 untreated and proteinase K-treated samples by in-solution tryptic digestion followed by analysis using 1D-liquid chromatography combined with a mass spectrometer (LC-MS/MS). C Eighteen host-incorporated proteins identified in purified proteinase treated TAdV-3 virions in the presence of proteolytic digestion are classified based on their known functions.
Cellular proteins associated with purified TAdV-3 virions after proteinase K treatment
|
| ||||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| - |
|
|
|
|
|
|
| - |
| Vitronectin | 52.2 | 4 | 100 | 5 | Cell adhesion | SIV21, KSHV29 |
|
|
|
|
|
|
|
|
| Collagen alpha-3 (VI) chain | 340 | 9 | 92 | 10 | Cell adhesion | - |
| Collagen alpha-2 (VI) chain | 110 | 5 | 91 | 5 | Cell adhesion | Influenza20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tyrosine protein phosphatase | 68 | 2 | 63 | 2 | Cell division | - |
| Antimicrobial peptide THP-2 | 7.6 | 7 | 64 | 48 | Innate immunity | - |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Protein subsets identified by LC-MS/MS with/without protease treatment are shown in bold black.
aTheoritical molecular mass.
bA Mascot score ≥30 is significant (p < 0.05).
cSequence coverage is based on peptides with an unique sequence.
Figure 4Western blot analysis of host proteins in TAdV-3. Proteins from the proteinase K untreated purified TAdV-3 virions (panels A, B, lane 1) and proteinase K (20 μg incubated in 1 mL of MNT buffer) treated purified TAdV-3 virions (panels A, B, lane 2) were separated by 10–15% SDS-PAGE, transferred to nitrocellulose and analyzed by Western blot using anti-collagen alpha-1(VI) chain serum (panel A) and anti-haemoglobin serum (panel B). Molecular weight markers (Lane M).